Pete Hegseth, President-elect Donald Trump’s nominee for Defense Secretary, will appear before the Senate on Tuesday morning.

Pete Hegseth’s nomination hearing on Tuesday ... which has been customary for past Defense chiefs. Jim Mattis and Lloyd Austin didn’t mention God much in their confirmation hearings for ...

A telling moment in the supremely depressing Senate confirmation hearing for Pete Hegseth, the Fox News personality who is Donald Trump’s pick for defense secretary, came right at the beginning, when the former Republican senator Norm Coleman introduced him.

The former combat veteran and TV news show host says he will be a “change agent” and a “warrior” for the department.

Wicker did not specify what day the vote would take place, but said it could be as late as next Thursday if Senate Democrats do not allow the chamber to speed up the confirmation process.

Democrats say Hegseth’s lack of experience, his past comments about women and Black troops and allegations of excessive drinking, and sexual misconduct, make him unfit to serve.

In what is expected to be the most rigorous confirmation hearing this week, Pete Hegseth, President-elect ... In contrast, Lloyd Austin’s “paper qualifications” led to utter failure in ...

A Democrat senator admitted Tuesday that he would support Secretary of Defense Lloyd Austin's confirmation again if the vote was held today despite Austin's many controversial actions and repeatedly grilling Trump's SecDef nominee Pete Hegseth over his qualifications earlier in the day.

Pete Hegseth, President-elect Donald Trump’s Defense secretary nominee, is scheduled for his Senate confirmation hearing tomorrow. Some have asked why

Pete Hegseth vowed to foster a "warrior culture" at the Pentagon and be a "change agent." He did not address the allegations of sexual assault and excessive drinking, focusing instead on his combat experience.

Defense Secretary Austin will bid farewell Friday following a term that included three major military crises, a global pandemic and a brush with cancer.